Recently an elegant study was published, where RTK MET was described in a novel signaling pathway with FIS1/DRP1 that promotes mitochondrial fragmentation and metastasis in hepatocellular carcinoma cells (Yu et al., 2021). Here, MET is linked to hepatocellular carcinoma.